psalexa
logo

Oligonucleotide Synthesis Market

Global Oligonucleotide Synthesis Market Size, Share, Development, Growth and Demand Forecast to 2023 - Industry Insight by Product (Synthesized Oligonucleotides, Reagents, Equipment), by Application (Research, Diagnostic, Therapeutic), by End User (Academic Research Institutes, Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Others)

Published: February 2017
Report Code: LS10302
Available Format:
Pages: 141
Category : Biotechnology

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Research Scope

1.3.1 Market segmentation by product

1.3.2 Market segmentation by application

1.3.3 Market segmentation by end user

1.3.4 Market segmentation by geography

1.3.5 Analysis Period

1.3.6 Market Data Reporting Unit

1.3.6.1 Value

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.2.1 Breakdown of Primary Research Respondents

2.2.1.1 By Region

2.2.1.2 By Industry Participants

2.2.1.3 By Company Type

2.3 Market Size Estimation

2.4 Market Breakdown and Data Triangulation

2.5 Assumptions for the Study

Chapter 3. Introduction

3.1 Market Segmentation

3.1.1 Overview by Product

3.1.1.1 Synthesized oligonucleotides

3.1.1.1.1 Synthesized oligonucleotides market by product

3.1.1.1.1.1 Primers

3.1.1.1.1.2 Probes

3.1.1.1.1.3 Large-scale synthesis oligonucleotides

3.1.1.1.1.4 Intermediate-scale synthesis oligonucleotides

3.1.1.1.1.5 Linkers & adaptors

3.1.1.1.2 Synthesized oligonucleotides market by service

3.1.1.1.2.1 Custom oligonucleotides

3.1.1.1.2.2 Pre-designed oligonucleotides

3.1.1.2 Reagents

3.1.1.3 Equipment

3.1.2 Overview by Application

3.1.2.1 Research

3.1.2.2 Diagnostic

3.1.2.3 Therapeutic

3.1.3 Overview by End User

3.1.3.1 Academic research institutes

3.1.3.2 Diagnostic laboratories

3.1.3.3 Pharmaceutical & biotechnology companies

3.2 Market Dynamics

3.2.1 Drivers

3.2.1.1 Recent advances in oligonucleotide synthesis

3.2.1.2 Increasing support from government organizations

3.2.1.3 Increasing research activities in synthetic biology

3.2.1.4 Increasing burden of cancer and infectious diseases

3.2.1.5 Impact analysis of drivers on market forecast

3.2.2 Restraints

3.2.2.1 Stringent regulatory requirements

3.2.2.2 Lack of techniques for large scale synthesis of oligonucleotide

3.2.2.3 Impact analysis of restraints on market forecast

3.2.3 Opportunities

3.2.3.1 Growing focus on personalized medicine

3.2.3.2 Increasing compliance for oligonucleotide synthesis in emerging markets

3.3 Porter’s Five Forces Analysis

3.3.1 Bargaining power of buyers

3.3.2 Bargaining power of suppliers

3.3.3 Threat of new entrants

3.3.4 Intensity of rivalry

3.3.5 Threat of substitutes

Chapter 4. Market Size and Forecast by Product

4.1 Global Synthesized Oligonucleotides Market

4.1.1 Global synthesized oligonucleotides market, by region

4.1.2 Global synthesized oligonucleotides market, by type

4.1.2.1 Global synthesized oligonucleotides market, by product

4.1.2.2 Global synthesized oligonucleotides market, by service

4.2 Global Oligonucleotide Synthesis Reagents Market

4.2.1 Global oligonucleotide synthesis reagents market, by  region

4.3 Global Oligonucleotide Synthesis Equipment Market

4.3.1 Global oligonucleotide synthesis equipment market, by region

Chapter 5. Market Size and Forecast by Application

5.1 Global Oligonucleotide Synthesis Market for Research, by Region

5.2 Global Oligonucleotide Synthesis Market for Diagnostic, by Region

5.3 Global Oligonucleotide Synthesis Market for Therapeutic, by Region

Chapter 6. Market Size and Forecast by End User

6.1 Global Oligonucleotide Synthesis Market for Academic Research Institutes, by Region

6.2 Global Oligonucleotide Synthesis Market for Diagnostic Laboratories, by Region

6.3 Global Oligonucleotide Synthesis Market for Pharmaceutical and Biotechnology Companies, by Region

Chapter 7. Market Size and Forecast by Geography

7.1 North America Oligonucleotide Synthesis Market

7.1.1 North America Oligonucleotide Synthesis Market, by Product

7.1.2 North America Oligonucleotide Synthesis Market, by Application

7.1.3 North America Oligonucleotide Synthesis Market, by End User

7.2 Europe Oligonucleotide Synthesis Market

7.2.1 Europe Oligonucleotide Synthesis Market, by Product

7.2.2 Europe Oligonucleotide Synthesis Market, by Application

7.2.3 Europe Oligonucleotide Synthesis Market, by End User

7.3 Asia-Pacific (APAC) Oligonucleotide Synthesis Market

7.3.1 APAC Oligonucleotide Synthesis Market, by Product

7.3.2 APAC Oligonucleotide Synthesis Market, by Application

7.3.3 APAC Oligonucleotide Synthesis Market, by End User

7.4 Latin America (LATAM) Oligonucleotide Synthesis Market

7.4.1 LATAM Oligonucleotide Synthesis Market, by Product

7.4.2 LATAM Oligonucleotide Synthesis Market, by Application

7.4.3 LATAM Oligonucleotide Synthesis Market, by End User

7.5 Middle East and Africa (MEA) Oligonucleotide Synthesis Market

7.5.1 MEA Oligonucleotide Synthesis Market, by Product

7.5.2 MEA Oligonucleotide Synthesis Market, by Application

7.5.3 MEA Oligonucleotide Synthesis Market, by End User

Chapter 8. Competitive Landscape

8.1 Benchmarking of Oligonucleotide Synthesis Products by Key Players

8.2 Global Strategic Developments

8.2.1 Mergers and Acquisitions

Chapter 9. Company Profiles

9.1 LGC Biosearch Technologies, Inc.

9.1.1 Business overview

9.1.2 Product and service offerings

9.2 Bioautomation Corporation

9.2.1 Business overview

9.2.2 Product and service offerings

9.3 Integrated DNA Technologies, Inc.

9.3.1 Business overview

9.3.2 Product and service offerings

9.4 GeneDesign, Inc.

9.4.1 Business overview

9.4.2 Product and service offerings

9.5 Trilink Biotechnologies LLC

9.5.1 Business overview

9.5.2 Product and service offerings

9.6 Merck KGaA

9.6.1 Business overview

9.6.2 Product and service offerings

9.7 Eurofins Scientific SE

9.7.1 Business overview

9.7.2 Product and service offerings

9.8 Thermo Fisher Scientific Inc.

9.8.1 Business overview

9.8.2 Product and service offerings

9.9 General Electric Company

9.9.1 Business overview

9.9.2 Product and service offerings

9.10 Eurogentec S.A.

9.10.1 Business overview

9.10.2 Product and service offerings

Chapter 10. Appendix

10.1 Abbreviations

 

LIST OF TABLES    

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 NUMBER OF WORLDWIDE MORTALITIES DUE TO VARIOUS DISEASES

TABLE 3 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 MAJOR NIH GUIDELINES IN THE U.S., BY EXPERIMENT TYPE

TABLE 5 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 6 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 7 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2017 – 2023)

TABLE 8 GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY REGION, $M (2013 – 2016)

TABLE 9 GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY REGION, $M (2017 – 2023)

TABLE 10 GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY TYPE, $M (2013 – 2016)

TABLE 11 GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY TYPE, $M (2017 – 2023)

TABLE 12 GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 13 GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY PRODUCT, $M (2017 – 2023)

TABLE 14 GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY SERVICE, $M (2013 – 2016)

TABLE 15 GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY SERVICE, $M (2017 – 2023)

TABLE 16 GLOBAL OLIGONUCLEOTIDE SYNTHESIS REAGENTS MARKET, BY REGION, $M (2013 – 2016)

TABLE 17 GLOBAL OLIGONUCLEOTIDE SYNTHESIS REAGENTS MARKET, BY REGION, $M (2017 – 2023)

TABLE 18 GLOBAL OLIGONUCLEOTIDE SYNTHESIS EQUIPMENT MARKET, BY REGION, $M (2013 – 2016)

TABLE 19 GLOBAL OLIGONUCLEOTIDE SYNTHESIS EQUIPMENT MARKET, BY REGION, $M (2017 – 2023)

TABLE 20 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2013 – 2016)

TABLE 21 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2017 – 2023)

TABLE 22 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH, BY REGION, $M (2013 – 2016)

TABLE 23 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH, BY REGION, $M (2017 – 2023)

TABLE 24 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DIAGNOSTIC, BY REGION, $M (2013 – 2016)

TABLE 25 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DIAGNOSTIC, BY REGION, $M (2017 – 2023)

TABLE 26 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC, BY REGION, $M (2013 – 2016)

TABLE 27 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC, BY REGION, $M (2017 – 2023)

TABLE 28 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2013 – 2016)

TABLE 29 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2017 – 2023)

TABLE 30 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, $M (2013 – 2016)

TABLE 31 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, $M (2017 – 2023)

TABLE 32 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, $M (2013 – 2016)

TABLE 33 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, $M (2017 – 2023)

TABLE 34 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, $M (2013 – 2016)

TABLE 35 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, $M (2017 – 2023)

TABLE 36 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 37 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2017 – 2023)

TABLE 38 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2013 – 2016)

TABLE 39 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2017 – 2023)

TABLE 40 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2013 – 2016)

TABLE 41 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2017 – 2023)

TABLE 42 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 43 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2017 – 2023)

TABLE 44 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2013 – 2016)

TABLE 45 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2017 – 2023)

TABLE 46 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2013 – 2016)

TABLE 47 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2017 – 2023)

TABLE 48 APAC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 49 APAC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2017 – 2023)

TABLE 50 APAC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2013 – 2016)

TABLE 51 APAC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2017 – 2023)

TABLE 52 APAC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2013 – 2016)

TABLE 53 APAC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2017 – 2023)

TABLE 54 LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 55 LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2017 – 2023)

TABLE 56 LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2013 – 2016)

TABLE 57 LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2017 – 2023)

TABLE 58 LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2013 – 2016)

TABLE 59 LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2017 – 2023)

TABLE 60 MEA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 61 MEA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2017 – 2023)

TABLE 62 MEA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2013 – 2016)

TABLE 63 MEA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2017 – 2023)

TABLE 64 MEA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2013 – 2016)

TABLE 65 MEA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2017 – 2023)

TABLE 66 LGC BIOSEARCH TECHNOLOGIES, INC. – AT A GLANCE

TABLE 67 BIOAUTOMATION CORPORATION – AT A GLANCE

TABLE 68 INTEGRATED DNA TECHNOLOGIES, INC. – AT A GLANCE

TABLE 69 GENEDESIGN, INC. – AT A GLANCE

TABLE 70 TRILINK BIOTECHNOLOGIES LLC – AT A GLANCE

TABLE 71 MERCK KGAA – AT A GLANCE

TABLE 72 EUROFINS SCIENTIFIC SE – AT A GLANCE

TABLE 73 THERMO FISHER SCIENTIFIC INC. – AT A GLANCE

TABLE 74 GENERAL ELECTRIC COMPANY – AT A GLANCE

TABLE 75 EUROGENTEC S.A.– AT A GLANCE

 

LIST OF FIGURES 

FIG 1 RESEARCH SCOPE FOR GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET

FIG 2 RESEARCH METHODOLOGY FOR THE GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET

FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH

FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION

FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT

FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE

FIG 7 DATA TRIANGULATION APPROACH FOR THE GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET

FIG 8 PORTERS FIVE FORCES ANALYSIS OF THE GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET

FIG 9 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SPLIT, BY PRODUCT (2016)

FIG 10 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2013 – 2023)

FIG 11 GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY REGION, $M (2013 – 2023)

FIG 12 GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY TYPE, $M (2013 – 2023)

FIG 13 GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY PRODUCT, $M (2013 – 2023)

FIG 14 GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY SERVICE, $M (2013 – 2023)

FIG 15 GLOBAL OLIGONUCLEOTIDE SYNTHESIS REAGENTS MARKET, BY REGION, $M (2013 – 2023)

FIG 16 GLOBAL OLIGONUCLEOTIDE SYNTHESIS EQUIPMENT MARKET, BY REGION, $M (2013 – 2023)

FIG 17 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SPLIT, BY APPLICATION (2016)

FIG 18 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2013 – 2023)

FIG 19 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH, BY REGION, $M (2013 – 2023)

FIG 20 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DIAGNOSTIC, BY REGION, $M (2013 – 2023)

FIG 21 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC, BY REGION, $M (2013 – 2023)

FIG 22 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SPLIT, BY END USER (2016)

FIG 23 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2013 – 2023)

FIG 24 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, $M (2013 – 2023)

FIG 25 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, $M (2013 – 2023)

FIG 26 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, $M (2013 – 2023)

FIG 27 WORLDWIDE MAJOR MARKETS FOR OLIGONUCLEOTIDE SYNTHESIS

FIG 28 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT

FIG 29 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2013 – 2023)

FIG 30 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2013 – 2023)

FIG 31 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2013 – 2023)

FIG 32 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT

FIG 33 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2013 – 2023)

FIG 34 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2013 – 2023)

FIG 35 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2013 – 2023)

FIG 36 APAC OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT

FIG 37 APAC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2013 – 2023)

FIG 38 APAC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2013 – 2023)

FIG 39 APAC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2013 – 2023)

FIG 40 LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT

FIG 41 LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2013 – 2023)

FIG 42 LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2013 – 2023)

FIG 43 LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2013 – 2023)

FIG 44 MEA OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT

FIG 45 MEA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2013 – 2023)

FIG 46 MEA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2013 – 2023)

FIG 47 MEA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2013 – 2023)

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 5100
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 6100
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 9100

Pre-Purchase Enquiry